Display options
Cite
Gori A, Rossi MC, Marchetti G, et al. Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease. AIDS. 2000;14(12):1859-61doi: 10.1097/00002030-200008180-00026.
Gori, A., Rossi, M. C., Marchetti, G., Trabattoni, D., Molteni, C., Cogliati, M., Bandera, A., Clerici, M., & Franzetti, F. (2000). Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease. AIDS (London, England), 14(12), 1859-61. https://doi.org/10.1097/00002030-200008180-00026
Gori, A, et al. "Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease." AIDS (London, England) vol. 14,12 (2000): 1859-61. doi: https://doi.org/10.1097/00002030-200008180-00026
Gori A, Rossi MC, Marchetti G, Trabattoni D, Molteni C, Cogliati M, Bandera A, Clerici M, Franzetti F. Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease. AIDS. 2000 Aug 18;14(12):1859-61. doi: 10.1097/00002030-200008180-00026. PMID: 10985328.
Copy Download .nbib Format: NLM
Share it on

AIDS. 2000 Aug 18;14(12):1859-61. doi: 10.1097/00002030-200008180-00026.

Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease.

AIDS (London, England)

A Gori, M C Rossi, G Marchetti, D Trabattoni, C Molteni, M Cogliati, A Bandera, M Clerici, F Franzetti

Affiliations

  1. Institute of Infectious Diseases and Tropical Medicine, University of Milan, Italy.

PMID: 10985328 DOI: 10.1097/00002030-200008180-00026

[No abstract available.]

Substances

MeSH terms

Publication Types